Baird Financial Group’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-29,723
Closed -$928K 1755
2024
Q3
$928K Buy
+29,723
New +$740K ﹤0.01% 1195
2020
Q3
Sell
-7,188
Closed -$255K 1496
2020
Q2
$255K Buy
+7,188
New +$205K ﹤0.01% 1355

Other funds holding CDNA

Baird Financial Group's CDNA Position: Q4 2024 in Review

Baird Financial Group sold out of CareDx (CDNA) in Q4 2024, closing a stake of 29,723 shares — an estimated $928K sold.

Baird Financial Group first reported a position in CDNA in Q2 2020 and held it in 2 quarters. The position peaked at $928K in Q3 2024. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.

  • Baird Financial Group reported no remaining CareDx position as of Q4 2024 after selling out during the quarter.
  • Baird Financial Group sold 29,723 CareDx shares in Q4 2024, an estimated $928K.
  • Baird Financial Group first reported a position in CareDx in Q2 2020 and held it in 2 quarters.
  • Baird Financial Group's CareDx position peaked at $928K in Q3 2024.
  • 210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.

Based on Baird Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.